Tag : PALLIATIVE RADIOTHERAPY

Laryngeal cancer is one of the most common types of head and neck cancers worldwide, with 5-year survival rates as high as 80%-90% for patients with early-stage tumors (i.e., stage I or II), and decrease sharply to 40% among those at advanced stage. Multimodal therapy combining surgery, radiotherapy and/or chemotherapy is often necessary for patients with advanced disease (i.e., stage III or IV). Certain patients such as the elderly may not be able to tolerate standard therapy well. However, these patients may need palliative treatment, which aims to improve their quality of life (QoL) and provide symptom relief. In this interview with Omnihealth Practice, Dr. Choy, Tim-Shing discussed the use of palliative radiotherapy among elderly patients with advanced laryngeal cancer and shared a clinical case todemonstrate its real-world applications.